Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,520 papers from all fields of science
Search
Sign In
Create Free Account
DN 9693
Known as:
DN-9693
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells
S. Kondo
,
N. Tanaka
,
+4 authors
M. Takigawa
Molecular Cancer Therapeutics
2006
Corpus ID: 11185810
Connective tissue growth factor (CTGF/CCN2) is a potent angiogenic factor. In this report, we describe for the first time that…
Expand
1995
1995
Effects of a New Inotropic Drug (DN‐9693) on Ca2+ Transients and Contraction in Ferret Ventricular Muscles
Tadashi Tanaka
,
M. Kawai
,
S. Kurihara
Journal of Cardiovascular Pharmacology
1995
Corpus ID: 45663027
We investigated the mechanisms of the effects of a newly synthesized cyclic AMP phosphodiesterase inhibitor (PDEI: l,5-dihydro-7…
Expand
1991
1991
Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP.
S. J. Gray
,
S. Heptinstall
European Journal of Pharmacology
1991
Corpus ID: 32200112
1991
1991
Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury.
C. Chang-chun
,
H. Matsuda
,
+6 authors
Y. Kawashima
Annals of Thoracic Surgery
1991
Corpus ID: 26088467
1989
1989
Effects of DN-9693, a synthesized phosphodiesterase inhibitor, on pancreatic exocrine secretion in dogs.
K. Iwatsuki
,
A. Horiuchi
,
H. Yonekura
,
K. Haruta
,
N. Homma
,
S. Chiba
Japanese Journal of Pharmacology
1989
Corpus ID: 24977697
The effects of DN-9693, a synthesized phosphodiesterase inhibitor, on the secretion of pancreatic juice were investigated in…
Expand
1987
1987
Comparison of vasodilator effects of DN-9693, a selective inhibitor of cyclic AMP phosphodiesterase, and isobutylmethylxanthine, a non-selective one, in dogs.
H. Hashimoto
,
K. Ishii
,
K. Satoh
,
N. Taira
Japanese Journal of Pharmacology
1987
Corpus ID: 36694507
The present experiments were performed in anesthetized dogs in order to determine if DN-9693, a new antiplatelet agent known to…
Expand
1987
1987
Determination of 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one (DN-9693) in human plasma and urine by high-performance liquid chromatography with electrochemical detection…
M. Tanaka
,
M. Yamada
,
K. Ono
,
T. Takegoshi
Journal of Pharmacy and Science
1987
Corpus ID: 28251044
A procedure for the determination of a newly developed antiadhesive agent, 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b…
Expand
1986
1986
Phosphorylation of phosphoinositides in human platelets.
K. Suga
,
Jun-ichi Kambayashi
,
T. Kawasaki
,
M. Sakon
,
T. Mori
Thrombosis Research
1986
Corpus ID: 29919792
1986
1986
Effects of DN-9693, a new metastasis inhibitor, on murine hematogenous metastasis.
N. Tanaka
,
A. Tohgo
,
H. Ogawa
,
Y. Osada
Anticancer Research
1986
Corpus ID: 11736673
1,5-Dihydro-7-(1-piperidinyl)-imidazo[2,1-b]quinazolin-2(3H)-one dihydrochloride hydrate (DN-9693), a new c-AMP…
Expand
1985
1985
Cyclic guanidines. 17. Novel (N-substituted amino)imidazo[2,1-b]quinazolin-2 ones: water-soluble platelet aggregation inhibitors.
F. Ishikawa
,
J. Saegusa
,
K. Inamura
,
K. Sakuma
,
S. Ashida
Journal of Medicinal Chemistry
1985
Corpus ID: 29672978
A series of novel 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one derivatives substituted with a secondary amino group has been…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE